{"id":"ppi-amoxicillin-clarithromycin","safety":{"commonSideEffects":[{"rate":"15-30","effect":"Diarrhea"},{"rate":"10-20","effect":"Nausea"},{"rate":"5-15","effect":"Abdominal pain"},{"rate":"5-10","effect":"Taste disturbance"},{"rate":"5-10","effect":"Headache"},{"rate":"1-3","effect":"Allergic reactions (amoxicillin)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The PPI suppresses gastric acid secretion, creating an optimal environment for the two antibiotics to penetrate the gastric mucosa and eliminate H. pylori. Amoxicillin and clarithromycin are bactericidal agents that target bacterial cell wall and protein synthesis respectively. This combination is a standard first-line or second-line regimen for H. pylori eradication.","oneSentence":"This is a triple-therapy combination that uses a proton pump inhibitor to reduce stomach acid while amoxicillin and clarithromycin work synergistically as antibiotics to eradicate Helicobacter pylori infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:02:00.815Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Helicobacter pylori infection eradication"}]},"trialDetails":[{"nctId":"NCT06156085","phase":"PHASE4","title":"Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy","status":"COMPLETED","sponsor":"Fu Jen Catholic University Hospital","startDate":"2023-11-14","conditions":"Helicobacter Pylori Infection","enrollment":337},{"nctId":"NCT07408271","phase":"","title":"The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-24","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Eradication Antibiotic","enrollment":83},{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT06349486","phase":"NA","title":"Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication","status":"RECRUITING","sponsor":"Kaohsiung Medical University","startDate":"2023-11-28","conditions":"Helicobacter Pylori Eradication","enrollment":390},{"nctId":"NCT07275827","phase":"PHASE3","title":"Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":88},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT07246681","phase":"PHASE3","title":"Lignin in Treatment of Helicobacter Pylori Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zagazig University","startDate":"2025-10-31","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":70},{"nctId":"NCT05332444","phase":"PHASE4","title":"Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2022-04-11","conditions":"Helicobacter Pylori Infection","enrollment":450},{"nctId":"NCT03431688","phase":"NA","title":"Tailored Therapy for Clarithromycin-Resistant H. Pylori","status":"COMPLETED","sponsor":"Kangdong Sacred Heart Hospital","startDate":"2018-10-01","conditions":"Helicobacter Pylori Infection","enrollment":782},{"nctId":"NCT07040839","phase":"PHASE4","title":"Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-07","conditions":"H Pylori","enrollment":128},{"nctId":"NCT06682533","phase":"","title":"Tegoprazan- Versus PPI-based H. Pylori Eradication","status":"RECRUITING","sponsor":"Soonchunhyang University Hospital","startDate":"2024-12-01","conditions":"H.Pylori Infection","enrollment":200},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT06200779","phase":"PHASE4","title":"Tailored Vs. Empirical Helicobacter Pylori Infection Treatment","status":"NOT_YET_RECRUITING","sponsor":"Manuel Coelho da Rocha","startDate":"2025-09","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT05475431","phase":"","title":"Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Comorbidities and Coexisting Conditions, Real-world Outcome","enrollment":1053},{"nctId":"NCT06168214","phase":"PHASE4","title":"Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2023-09-04","conditions":"the Eradication Rates of Helicobacter Pylori","enrollment":1404},{"nctId":"NCT04147065","phase":"PHASE4","title":"Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study)","status":"RECRUITING","sponsor":"Incheon St.Mary's Hospital","startDate":"2021-07-14","conditions":"Helicobacter Pylori Infection","enrollment":1230},{"nctId":"NCT06414707","phase":"PHASE3","title":"Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-10-12","conditions":"Helicobacter Pylori Infection","enrollment":320},{"nctId":"NCT06382493","phase":"NA","title":"Tegoprazan-containing Sequential for H. Pylori","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2021-02-01","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT05664685","phase":"PHASE4","title":"Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-10-17","conditions":"Helicobacter Pylori Infection","enrollment":127},{"nctId":"NCT06318104","phase":"PHASE4","title":"Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole","status":"NOT_YET_RECRUITING","sponsor":"Hospital General de México Dr. Eduardo Liceaga","startDate":"2024-04-19","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT06315478","phase":"PHASE4","title":"Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians","status":"COMPLETED","sponsor":"Helwan University","startDate":"2021-02-01","conditions":"H.Pylori Infection","enrollment":60},{"nctId":"NCT06275204","phase":"","title":"H. Pylori Screen-and-treat Study in a Population of Young Adults","status":"RECRUITING","sponsor":"University of Latvia","startDate":"2024-03-04","conditions":"Gastric Cancer, H Pylori Infection, H Pylori Eradication","enrollment":6800},{"nctId":"NCT05549115","phase":"NA","title":"Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Liaocheng People's Hospital","startDate":"2022-09-20","conditions":"Helicobacter Pylori Infection","enrollment":500},{"nctId":"NCT02407119","phase":"PHASE3","title":"Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2003-06","conditions":"Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection","enrollment":470},{"nctId":"NCT01678027","phase":"PHASE3","title":"Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2004-11","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Family Members","enrollment":1838},{"nctId":"NCT06101420","phase":"PHASE3","title":"Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Helicobacter Pylori Eradication","enrollment":232},{"nctId":"NCT01273441","phase":"PHASE4","title":"Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice","status":"COMPLETED","sponsor":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","startDate":"2010-12","conditions":"Helicobacter Pylori","enrollment":338},{"nctId":"NCT05371249","phase":"PHASE4","title":"Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy","status":"UNKNOWN","sponsor":"Fu Jen Catholic University Hospital","startDate":"2021-12-01","conditions":"Helicobacter Pylori","enrollment":628},{"nctId":"NCT05718609","phase":"PHASE4","title":"Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-01","conditions":"Helicobacter Pylori Infection","enrollment":855},{"nctId":"NCT02373280","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":600},{"nctId":"NCT02359331","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection","status":"TERMINATED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":370},{"nctId":"NCT05419674","phase":"PHASE4","title":"Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-08-01","conditions":"Helicobacter Pylori Infection","enrollment":393},{"nctId":"NCT04660123","phase":"PHASE4","title":"A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":959},{"nctId":"NCT04853875","phase":"PHASE4","title":"ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, Clarithromycin","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2021-04-19","conditions":"Helicobacter Pylori Infection","enrollment":104},{"nctId":"NCT05590286","phase":"PHASE4","title":"A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"First People's Hospital of Hangzhou","startDate":"2022-06-01","conditions":"Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor","enrollment":100},{"nctId":"NCT05152004","phase":"NA","title":"Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2018-09-01","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT05455372","phase":"NA","title":"Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2022-07-08","conditions":"Helicobacter Pylori Infection","enrollment":600},{"nctId":"NCT05301725","phase":"","title":"Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori; Eradication Rate","enrollment":670},{"nctId":"NCT04178187","phase":"NA","title":"The Role of Probiotics in the Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Evangelismos Hospital","startDate":"2019-10-02","conditions":"Helicobacter Pylori Infection","enrollment":660},{"nctId":"NCT05226819","phase":"NA","title":"Influencing Factors of Helicobacter Pylori Infection and Eradication Failure","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2022-02-06","conditions":"Helicobacter Pylori Infection","enrollment":300},{"nctId":"NCT05191888","phase":"PHASE4","title":"14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","startDate":"2021-08-06","conditions":"Helicobacter Pylori Eradication","enrollment":906},{"nctId":"NCT04558502","phase":"PHASE4","title":"Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-01-05","conditions":"Helicobacter Pylori Eradication","enrollment":339},{"nctId":"NCT04901663","phase":"PHASE4","title":"Vonoprazan in Helicobacter Pylori Treatment an RCT","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2021-06-21","conditions":"Helicobacter Pylori Infection","enrollment":179},{"nctId":"NCT04769583","phase":"PHASE4","title":"14-day Quadruple Therapy Versus Triple Therapy in HP Eradication","status":"COMPLETED","sponsor":"mohamed bouchoucha","startDate":"2019-02-10","conditions":"Gastritis H Pylori","enrollment":121},{"nctId":"NCT04721704","phase":"NA","title":"Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children","status":"UNKNOWN","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2020-09-14","conditions":"H Pylori Gastritis","enrollment":36},{"nctId":"NCT04697641","phase":"NA","title":"Helicobacter Pylori Eradication in Functional Dyspepsia","status":"COMPLETED","sponsor":"Sir Ganga Ram Hospital","startDate":"2017-09-01","conditions":"Dyspepsia, Helicobacter Pylori Infection","enrollment":202},{"nctId":"NCT04107194","phase":"PHASE3","title":"Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.","status":"UNKNOWN","sponsor":"University of Bari","startDate":"2020-01-14","conditions":"Helicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain","enrollment":362},{"nctId":"NCT04668534","phase":"NA","title":"Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Functional Dyspepsia","status":"UNKNOWN","sponsor":"Air Force Military Medical University, China","startDate":"2020-11-01","conditions":"Functional Dyspepsia","enrollment":300},{"nctId":"NCT03908619","phase":"PHASE4","title":"A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis","status":"UNKNOWN","sponsor":"Changi General Hospital","startDate":"2019-04-16","conditions":"Helicobacter Pylori Infection","enrollment":252},{"nctId":"NCT04445948","phase":"PHASE4","title":"Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2019-11-30","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT03050359","phase":"PHASE3","title":"Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-04-05","conditions":"Duodenal Ulcer","enrollment":533},{"nctId":"NCT03658746","phase":"PHASE4","title":"Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Shandong University","startDate":"2019-01-01","conditions":"Helicobacter Pylori Infection","enrollment":420},{"nctId":"NCT02557932","phase":"PHASE3","title":"Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2015-09","conditions":"Helicobacter Pylori Infection, Family History of Stomach Cancer","enrollment":352},{"nctId":"NCT03172676","phase":"PHASE4","title":"Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-01-01","conditions":"Immune Thrombocytopenia","enrollment":75},{"nctId":"NCT03220542","phase":"PHASE4","title":"The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2016-01","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT03837990","phase":"","title":"One Sequencing Find All for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2019-05-01","conditions":"Helicobacter Pylori Infection, Resistant Infection","enrollment":60},{"nctId":"NCT03219723","phase":"","title":"Drug Use Surveillance of Takecab for \"Supplement to Helicobacter Pylori Eradication\"","status":"COMPLETED","sponsor":"Takeda","startDate":"2015-09-01","conditions":"Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other","enrollment":560},{"nctId":"NCT03884348","phase":"","title":"Tailored H. Pylori Eradication Based on Clarithromycin Resistance","status":"COMPLETED","sponsor":"Kangdong Sacred Heart Hospital","startDate":"2017-01-01","conditions":"Helicobacter Pylori Infection, Antibiotic Resistant Strain","enrollment":431},{"nctId":"NCT03516669","phase":"PHASE4","title":"Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2018-05-07","conditions":"Helicobacter Pylori Infection","enrollment":20},{"nctId":"NCT03383003","phase":"NA","title":"Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-03-01","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT03802318","phase":"NA","title":"Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-01-02","conditions":"Helicobacter Pylori Infection, Helicobacter Gastritis, Helicobacter-Associated Pyloric Ulcer","enrollment":530},{"nctId":"NCT03021590","phase":"PHASE4","title":"Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori","status":"WITHDRAWN","sponsor":"Damascus Hospital","startDate":"2017-06-01","conditions":"Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":""},{"nctId":"NCT03654781","phase":"PHASE1","title":"Impact of Periodontal Treatment on Gastric Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2008-04-21","conditions":"Helicobacter Pylori Infection","enrollment":98},{"nctId":"NCT03650543","phase":"PHASE4","title":"Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Javeriana University","startDate":"2012-09-10","conditions":"CYP2C19 Polymorphism, H.Pylori Infection, Therapy","enrollment":133},{"nctId":"NCT02935010","phase":"PHASE4","title":"Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2017-02-05","conditions":"Helicobacter Pylori Infection","enrollment":382},{"nctId":"NCT03413020","phase":"PHASE4","title":"Tailored Therapy for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-01-03","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT03583476","phase":"","title":"The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2018-04-01","conditions":"Helicobacter Pylori Infection","enrollment":1821},{"nctId":"NCT03571230","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":400},{"nctId":"NCT02959255","phase":"PHASE4","title":"10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection","status":"COMPLETED","sponsor":"Elpen Pharmaceutical Co. Inc.","startDate":"2017-01-30","conditions":"Helicobacter Pylori Infection","enrollment":364},{"nctId":"NCT03362281","phase":"PHASE3","title":"Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients","status":"COMPLETED","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2014-10","conditions":"Peptic Ulcer Hemorrhage","enrollment":540},{"nctId":"NCT02576236","phase":"NA","title":"Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-05","conditions":"H Pylori Infection Eradication, Antibiotics Therapeutic Strategies, H Pylori Eradication","enrollment":2500},{"nctId":"NCT03139253","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment","status":"UNKNOWN","sponsor":"Yanqing Li","startDate":"2017-05-30","conditions":"Antimicrobial Susceptibility Testing, Triple Therapy","enrollment":120},{"nctId":"NCT02988089","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2017-04-20","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":480},{"nctId":"NCT02359435","phase":"NA","title":"Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2012-10","conditions":"Helicobacter Pylori Infection","enrollment":440},{"nctId":"NCT03099876","phase":"","title":"A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients","status":"UNKNOWN","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2017-03-01","conditions":"Helicobacter Pylori Infection","enrollment":320},{"nctId":"NCT02693574","phase":"PHASE4","title":"Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori","status":"UNKNOWN","sponsor":"Damascus Hospital","startDate":"2015-12-01","conditions":"Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":74},{"nctId":"NCT01264822","phase":"","title":"Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2011-01-13","conditions":"Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive","enrollment":108},{"nctId":"NCT02934152","phase":"PHASE4","title":"Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2016-10","conditions":"Gastroesophageal Reflux Disease","enrollment":400},{"nctId":"NCT02934048","phase":"PHASE4","title":"Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2016-10","conditions":"Therapeutic Duration, Helicobacter Pylori, Antimicrobial Susceptibility Test","enrollment":700},{"nctId":"NCT02349685","phase":"NA","title":"The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2010-01","conditions":"Helicobacter Infection","enrollment":219},{"nctId":"NCT02741414","phase":"NA","title":"A Multi-center Study for Eradication of Refractory Helicobacter Pylori","status":"UNKNOWN","sponsor":"Taizhou Hospital","startDate":"2016-06","conditions":"Gastritis","enrollment":4428},{"nctId":"NCT02689583","phase":"NA","title":"A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2016-03","conditions":"Gastritis, Gastric Ulcer","enrollment":3000},{"nctId":"NCT02682446","phase":"","title":"The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2007-01","conditions":"Gastric Cancer","enrollment":800},{"nctId":"NCT02635191","phase":"PHASE4","title":"Tailored Therapy for Helicobacter Pylori in Children","status":"UNKNOWN","sponsor":"Beijing Children's Hospital","startDate":"2014-03","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT01085786","phase":"PHASE4","title":"Sequential and Hybrid Therapies for H Pylori Infection","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2008-08","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT01481844","phase":"PHASE3","title":"Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection","status":"COMPLETED","sponsor":"Soroka University Medical Center","startDate":"2011-11","conditions":"Optimization of Second Line Treatment Protocol for H Pylori Eradication","enrollment":101},{"nctId":"NCT01418300","phase":"PHASE4","title":"Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial","status":"COMPLETED","sponsor":"Jun-Won Chung","startDate":"2010-08","conditions":"Helicobacter Infected Patients","enrollment":159},{"nctId":"NCT01888237","phase":"PHASE4","title":"High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2013-05","conditions":"Dyspepsia, Helicobacter-associated Gastritis, Stomach Disorders","enrollment":118},{"nctId":"NCT02175901","phase":"PHASE4","title":"Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2014-07","conditions":"Dyspepsia, Peptic Ulcer","enrollment":215},{"nctId":"NCT02249546","phase":"PHASE4","title":"Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2014-09","conditions":"Helicobacter Pylori Infection","enrollment":654},{"nctId":"NCT02092506","phase":"PHASE4","title":"RCT: Triple vs Sequential vs Concomitant Therapy H Pylori","status":"COMPLETED","sponsor":"Changi General Hospital","startDate":"2011-12","conditions":"Bacterial Infection Due to Helicobacter Pylori (H. Pylori)","enrollment":462},{"nctId":"NCT01168063","phase":"NA","title":"Molecular Detection of Antibiotic Resistance and H Pylori Eradication","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-02","conditions":"Helicobacter Pylori Infection","enrollment":1386},{"nctId":"NCT01922505","phase":"","title":"Eradication Rates of Helicobacter Pylori and Its Affecting Factors","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2003-01","conditions":"Helicobacter Infections","enrollment":2500},{"nctId":"NCT01887249","phase":"PHASE4","title":"15-day Sequential Therapy for Helicobacter Pylori Infection in Korea","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2010-05","conditions":"Helicobacter Pylori Infection","enrollment":287},{"nctId":"NCT01667575","phase":"PHASE4","title":"Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2012-08","conditions":"Functional Dyspepsia, Peptic Ulcer, Helicobacter Pylori","enrollment":180},{"nctId":"NCT01464060","phase":"PHASE4","title":"14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Infante, Javier Molina, M.D.","startDate":"2011-09","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT01730352","phase":"PHASE2, PHASE3","title":"Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2008-10","conditions":"Immune Thrombocytopenic Purpura, Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT00926809","phase":"PHASE4","title":"H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection","status":"UNKNOWN","sponsor":"Korean College of Helicobacter and Upper Gastrointestinal Research","startDate":"2008-09","conditions":"Ulcer","enrollment":232},{"nctId":"NCT00719420","phase":"PHASE3","title":"Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia","status":"COMPLETED","sponsor":"University of North Texas Health Science Center","startDate":"2006-04","conditions":"Helicobacter Pylori Infection","enrollment":151},{"nctId":"NCT00154440","phase":"PHASE3","title":"Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation","status":"UNKNOWN","sponsor":"Technische Universität Dresden","startDate":"2001-11","conditions":"Lymphoma, Lymphoma, Non-Hodgkin","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":32,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"PPI-amoxicillin-clarithromycin","genericName":"PPI-amoxicillin-clarithromycin","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a triple-therapy combination that uses a proton pump inhibitor to reduce stomach acid while amoxicillin and clarithromycin work synergistically as antibiotics to eradicate Helicobacter pylori infection. Used for Helicobacter pylori infection eradication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}